[8-K] Tecogen Inc. Reports Material Event
On 21 Jul 2025, Tecogen Inc. (TGEN) filed an 8-K announcing the closing of a firm-commitment underwritten public offering of 3,985,000 common shares (incl. 485,000 overallotment) at $5.00 per share. Gross proceeds equal roughly $19.9 million; after underwriting discounts and estimated expenses, net proceeds are about $18.16 million.
Roth Capital Partners served as sole manager and underwriter. Management intends to allocate the cash to product development, expanded sales & marketing, additional staffing, capital expenditures, and working capital as the company pursues entry into the data-center market. Exhibit 99.1 contains a related press release, furnished but not deemed filed under the Exchange Act.
Il 21 luglio 2025, Tecogen Inc. (TGEN) ha presentato un modulo 8-K annunciando la chiusura di un'offerta pubblica sottoscritta a impegno fermo di 3.985.000 azioni ordinarie (incluso un overallotment di 485.000) a 5,00 $ per azione. I proventi lordi ammontano a circa 19,9 milioni di dollari; dopo gli sconti di sottoscrizione e le spese stimate, i proventi netti sono circa 18,16 milioni di dollari.
Roth Capital Partners ha operato come unico gestore e sottoscrittore. Il management intende destinare i fondi allo sviluppo del prodotto, all'espansione delle vendite e del marketing, all'assunzione di personale aggiuntivo, alle spese in conto capitale e al capitale circolante, mentre l'azienda si prepara a entrare nel mercato dei data center. L'Esibizione 99.1 contiene un comunicato stampa correlato, fornito ma non considerato depositato ai sensi dell'Exchange Act.
El 21 de julio de 2025, Tecogen Inc. (TGEN) present贸 un formulario 8-K anunciando el cierre de una oferta p煤blica suscrita con compromiso firme de 3.985.000 acciones ordinarias (incluyendo 485.000 en sobresuscripci贸n) a $5.00 por acci贸n. Los ingresos brutos son aproximadamente $19.9 millones; despu茅s de los descuentos de suscripci贸n y gastos estimados, los ingresos netos son cerca de $18.16 millones.
Roth Capital Partners actu贸 como 煤nico administrador y suscriptor. La direcci贸n tiene la intenci贸n de destinar el efectivo al desarrollo de productos, expansi贸n de ventas y marketing, contrataci贸n adicional, gastos de capital y capital de trabajo mientras la empresa busca ingresar al mercado de centros de datos. El Anexo 99.1 contiene un comunicado de prensa relacionado, proporcionado pero no considerado presentado bajo la Exchange Act.
2025雲� 7鞗� 21鞚�, Tecogen Inc. (TGEN)鞚� 8-K 靹滊毳� 鞝滌稖頃橃棳 3,985,000欤检潣 氤错喌欤�(485,000欤� 鞓る矂鞏茧韸� 韽暔)毳� 欤茧嫻 $5.00鞐� 頇曥爼 鞚胳垬 瓿惦毳� 毵堦皭頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. 齑� 靾橃澋鞚� 鞎� $19.9氚彪鞚措┌, 鞚胳垬 靾橃垬耄� 氚� 於旍爼 瓴诫箘毳� 鞝滌櫢頃� 靾滌垬鞚奠潃 鞎� $18.16氚彪鞛呺媹雼�.
Roth Capital Partners臧� 雼弲 毵る媹鞝�鞚挫瀽 鞚胳垬鞚胳溂搿� 鞐暊鞚� 靾橅枆頄堨姷雼堧嫟. 瓴届榿歆勳潃 順勱笀鞚� 鞝滍拡 臧滊皽, 韺愲Г 氚� 毵堨紑韺� 頇曤寑, 於旉皜 鞚鸽牓 毂勳毄, 鞛愲掣 歆�於� 氚� 鞖挫爠鞛愲掣鞐� 氚半秳頃� 瓿勴殟鞚措┌, 須岇偓電� 雿办澊韯� 靹柬劙 鞁滌灔 歆勳瀰鞚� 於旍頃橁碃 鞛堨姷雼堧嫟. 攵�靻嶌劀 99.1鞐愲姅 甏�霠� 氤措弰鞛愲臧� 韽暔霅橃柎 鞛堨溂氅�, 鞚措姅 鞝滉车霅橃棃鞙茧倶 瓯半灅氩�(Exchange Act)靸� 鞝滌稖霅� 瓴冹溂搿� 臧勳＜霅橃 鞎婌姷雼堧嫟.
Le 21 juillet 2025, Tecogen Inc. (TGEN) a d茅pos茅 un formulaire 8-K annon莽ant la cl么ture d'une offre publique souscrite ferme de 3 985 000 actions ordinaires (dont 485 000 en option de surallocation) au prix de 5,00 $ par action. Le produit brut s'茅l猫ve 脿 environ 19,9 millions de dollars; apr猫s d茅duction des remises de souscription et des frais estim茅s, le produit net est d'environ 18,16 millions de dollars.
Roth Capital Partners a agi en tant que gestionnaire et souscripteur unique. La direction pr茅voit d'affecter les fonds au d茅veloppement de produits, 脿 l'expansion des ventes et du marketing, 脿 l'embauche de personnel suppl茅mentaire, aux d茅penses d'investissement et au fonds de roulement, alors que la soci茅t茅 envisage d'entrer sur le march茅 des centres de donn茅es. L'annexe 99.1 contient un communiqu茅 de presse connexe, fourni mais non consid茅r茅 comme d茅pos茅 en vertu de la Exchange Act.
Am 21. Juli 2025 reichte Tecogen Inc. (TGEN) ein Formular 8-K ein, in dem der Abschluss eines festverpflichteten, gezeichneten 枚ffentlichen Angebots von 3.985.000 Stammaktien (inkl. 485.000 Mehrzuteilungen) zu je 5,00 $ pro Aktie bekannt gegeben wurde. Die Bruttoerl枚se belaufen sich auf rund 19,9 Millionen $; nach Abzug von Zeichnungsrabatten und gesch盲tzten Kosten betragen die Nettoerl枚se etwa 18,16 Millionen $.
Roth Capital Partners fungierte als alleiniger Manager und Underwriter. Das Management beabsichtigt, die Mittel f眉r Produktentwicklung, erweiterten Vertrieb und Marketing, zus盲tzliche Personalaufstockung, Investitionsausgaben und Betriebskapital einzusetzen, w盲hrend das Unternehmen den Einstieg in den Rechenzentrumsmarkt anstrebt. Anlage 99.1 enth盲lt eine zugeh枚rige Pressemitteilung, die bereitgestellt, aber nicht als eingereicht im Sinne des Exchange Act angesehen wird.
- $18.16 million in net cash strengthens liquidity and funds expansion into the data-center market.
- Successful firm-commitment underwriting by Roth Capital indicates institutional confidence.
- Exercise of the 485,000-share overallotment points to stronger-than-expected demand.
- Issuance of 3.985 million new shares increases outstanding share count, potentially diluting existing shareholders鈥� ownership and near-term EPS.
Insights
TL;DR: $18.2 M equity raise boosts liquidity for data-center growth; share issuance modestly dilutes owners but signals market support.
The successful firm-commitment offering provides Tecogen with fresh capital equal to roughly one year of its historical revenue base, materially strengthening the balance sheet without adding debt. Use-of-proceeds targets higher-growth verticals (data centers) that could expand addressable market and margin profile. Roth Capital鈥檚 sole-manager role and exercise of the overallotment option imply healthy institutional demand. However, issuing nearly 4 million shares will increase the outstanding share count and could pressure per-share metrics until growth materializes. Overall, the transaction is strategically positive and only moderately dilutive, so impact is viewed as favorable.
Il 21 luglio 2025, Tecogen Inc. (TGEN) ha presentato un modulo 8-K annunciando la chiusura di un'offerta pubblica sottoscritta a impegno fermo di 3.985.000 azioni ordinarie (incluso un overallotment di 485.000) a 5,00 $ per azione. I proventi lordi ammontano a circa 19,9 milioni di dollari; dopo gli sconti di sottoscrizione e le spese stimate, i proventi netti sono circa 18,16 milioni di dollari.
Roth Capital Partners ha operato come unico gestore e sottoscrittore. Il management intende destinare i fondi allo sviluppo del prodotto, all'espansione delle vendite e del marketing, all'assunzione di personale aggiuntivo, alle spese in conto capitale e al capitale circolante, mentre l'azienda si prepara a entrare nel mercato dei data center. L'Esibizione 99.1 contiene un comunicato stampa correlato, fornito ma non considerato depositato ai sensi dell'Exchange Act.
El 21 de julio de 2025, Tecogen Inc. (TGEN) present贸 un formulario 8-K anunciando el cierre de una oferta p煤blica suscrita con compromiso firme de 3.985.000 acciones ordinarias (incluyendo 485.000 en sobresuscripci贸n) a $5.00 por acci贸n. Los ingresos brutos son aproximadamente $19.9 millones; despu茅s de los descuentos de suscripci贸n y gastos estimados, los ingresos netos son cerca de $18.16 millones.
Roth Capital Partners actu贸 como 煤nico administrador y suscriptor. La direcci贸n tiene la intenci贸n de destinar el efectivo al desarrollo de productos, expansi贸n de ventas y marketing, contrataci贸n adicional, gastos de capital y capital de trabajo mientras la empresa busca ingresar al mercado de centros de datos. El Anexo 99.1 contiene un comunicado de prensa relacionado, proporcionado pero no considerado presentado bajo la Exchange Act.
2025雲� 7鞗� 21鞚�, Tecogen Inc. (TGEN)鞚� 8-K 靹滊毳� 鞝滌稖頃橃棳 3,985,000欤检潣 氤错喌欤�(485,000欤� 鞓る矂鞏茧韸� 韽暔)毳� 欤茧嫻 $5.00鞐� 頇曥爼 鞚胳垬 瓿惦毳� 毵堦皭頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. 齑� 靾橃澋鞚� 鞎� $19.9氚彪鞚措┌, 鞚胳垬 靾橃垬耄� 氚� 於旍爼 瓴诫箘毳� 鞝滌櫢頃� 靾滌垬鞚奠潃 鞎� $18.16氚彪鞛呺媹雼�.
Roth Capital Partners臧� 雼弲 毵る媹鞝�鞚挫瀽 鞚胳垬鞚胳溂搿� 鞐暊鞚� 靾橅枆頄堨姷雼堧嫟. 瓴届榿歆勳潃 順勱笀鞚� 鞝滍拡 臧滊皽, 韺愲Г 氚� 毵堨紑韺� 頇曤寑, 於旉皜 鞚鸽牓 毂勳毄, 鞛愲掣 歆�於� 氚� 鞖挫爠鞛愲掣鞐� 氚半秳頃� 瓿勴殟鞚措┌, 須岇偓電� 雿办澊韯� 靹柬劙 鞁滌灔 歆勳瀰鞚� 於旍頃橁碃 鞛堨姷雼堧嫟. 攵�靻嶌劀 99.1鞐愲姅 甏�霠� 氤措弰鞛愲臧� 韽暔霅橃柎 鞛堨溂氅�, 鞚措姅 鞝滉车霅橃棃鞙茧倶 瓯半灅氩�(Exchange Act)靸� 鞝滌稖霅� 瓴冹溂搿� 臧勳＜霅橃 鞎婌姷雼堧嫟.
Le 21 juillet 2025, Tecogen Inc. (TGEN) a d茅pos茅 un formulaire 8-K annon莽ant la cl么ture d'une offre publique souscrite ferme de 3 985 000 actions ordinaires (dont 485 000 en option de surallocation) au prix de 5,00 $ par action. Le produit brut s'茅l猫ve 脿 environ 19,9 millions de dollars; apr猫s d茅duction des remises de souscription et des frais estim茅s, le produit net est d'environ 18,16 millions de dollars.
Roth Capital Partners a agi en tant que gestionnaire et souscripteur unique. La direction pr茅voit d'affecter les fonds au d茅veloppement de produits, 脿 l'expansion des ventes et du marketing, 脿 l'embauche de personnel suppl茅mentaire, aux d茅penses d'investissement et au fonds de roulement, alors que la soci茅t茅 envisage d'entrer sur le march茅 des centres de donn茅es. L'annexe 99.1 contient un communiqu茅 de presse connexe, fourni mais non consid茅r茅 comme d茅pos茅 en vertu de la Exchange Act.
Am 21. Juli 2025 reichte Tecogen Inc. (TGEN) ein Formular 8-K ein, in dem der Abschluss eines festverpflichteten, gezeichneten 枚ffentlichen Angebots von 3.985.000 Stammaktien (inkl. 485.000 Mehrzuteilungen) zu je 5,00 $ pro Aktie bekannt gegeben wurde. Die Bruttoerl枚se belaufen sich auf rund 19,9 Millionen $; nach Abzug von Zeichnungsrabatten und gesch盲tzten Kosten betragen die Nettoerl枚se etwa 18,16 Millionen $.
Roth Capital Partners fungierte als alleiniger Manager und Underwriter. Das Management beabsichtigt, die Mittel f眉r Produktentwicklung, erweiterten Vertrieb und Marketing, zus盲tzliche Personalaufstockung, Investitionsausgaben und Betriebskapital einzusetzen, w盲hrend das Unternehmen den Einstieg in den Rechenzentrumsmarkt anstrebt. Anlage 99.1 enth盲lt eine zugeh枚rige Pressemitteilung, die bereitgestellt, aber nicht als eingereicht im Sinne des Exchange Act angesehen wird.
FAQ
How many shares did Tecogen (TGEN) issue in its July 2025 public offering?
What was the offering price for Tecogen鈥檚 new shares?
What net proceeds did Tecogen receive from the offering?
How will Tecogen use the cash raised in the offering?
Who acted as the underwriter for Tecogen鈥檚 equity offering?
Is the related press release considered "filed" for liability purposes?
